- $634.27m
- $410.97m
- $367.25m
- 64
- 78
- 13
- 51
Annual income statement for Ibotta, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 211 | 320 | 367 |
| Cost of Revenue | |||
| Gross Profit | 165 | 276 | 317 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 251 | 264 | 349 |
| Operating Profit | -40.3 | 56 | 18.2 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | -54.6 | 44.1 | 24.5 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -54.9 | 38.1 | 68.7 |
| Net Income Before Extraordinary Items | |||
| Net Income | -54.9 | 38.1 | 68.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -54.9 | 38.1 | 68.7 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -1.7 | 1.27 | 2.81 |